
ASCE+ SRLV-E is an ExoCoBio two-part professional topical kit whose published label identifies a lyophilized powder and diluent for wrinkle care and skin rejuvenation.
Its U.S. DailyMed entry is a label record, not FDA approval, and explicitly categorizes the product as unapproved. Clinics should distinguish ExoCoBio's product positioning and ingredient disclosures from independently proven outcomes for a specific treatment protocol.
Catalogue visual: ASCE+ SRLV-E (Derma Signal Kit) from the NEES Medical product catalogue. Packaging appearance alone does not establish authenticity; verify the supplied batch, expiry, seals and traceability documents.
The ASCE+ Derma Signal Kit SRLV is described in DailyMed as a topical kit labeled by ExoCoBio. The record lists leucine and isoleucine as active ingredients and includes Rosa damascena callus extracellular vesicles, peptides, amino acids and other components in the powder, with sodium hyaluronate among the diluent ingredients.
The published route is topical, the pack is identified as single-use, and the label states 2–8°C storage. This article does not recommend an administration procedure and does not treat the presence of extracellular vesicles as proof of a licensed biologic therapy.
SRLV-E is positioned in professional post-procedure and skin-quality care. Its value proposition differs from a regulated dermal filler, prescription medicine or energy-based device, so comparisons should focus on intended role, evidence and regulatory status rather than a single promise such as rejuvenation.
| Category | What it is intended to do | Key distinction |
|---|---|---|
| ASCE+ SRLV-E | Manufacturer-positioned professional topical skin-care kit. | DailyMed records the topical label but states that it is unapproved and not found by FDA to be safe and effective. |
| Hyaluronic acid skin products or fillers | Range from topical moisturization to regulated injectable volume correction. | Material, route and risk profile differ; an injectable filler is a medical device and not equivalent to SRLV-E. |
| Platelet-rich plasma | Autologous procedure used by some clinics for skin-quality indications. | Requires blood processing and a clinical procedure; evidence and protocols vary. |
| Standard post-procedure skincare | Barrier support and symptom-focused cosmetic care. | Often simpler and lower cost, with product choice driven by the procedure and skin tolerance. |
ASCE+ SRLV-E Derma Signal Kit pricing in Pakistan is supplied by quotation. Confirm the exact kit, available quantity, batch, expiry, refrigerated delivery conditions and included documentation before comparing offers.
The lowest advertised price is not necessarily the lowest procurement risk when the seller cannot document product identity and temperature history.
View the ASCE+ SRLV-E (Derma Signal Kit) catalogue page or request current pricing and availability.
What is the ASCE+ SRLV-E price in Pakistan?
A current quotation is required. Ask for stock, exact kit presentation, batch, expiry, cold-chain delivery and documentation in the written quote.
Is a DailyMed listing proof that SRLV-E is FDA-approved?
No. The DailyMed record explicitly says the product has not been found by FDA to be safe and effective and that its labeling has not been approved by FDA.
How can a clinic check ASCE+ SRLV-E authenticity?
Verify ExoCoBio identity, intact powder and diluent components, matching batch and expiry data, invoice, refrigerated handling and any official authentication feature on the supplied pack.
How should ASCE+ SRLV-E be stored and how long does it last?
The published label states 2–8°C storage. Use the expiry on the intact kit and obtain evidence that the required temperature was maintained through distribution.
When should visible skin results appear?
A universal product-specific timeline is not established by high-quality independent trials. Timing depends on baseline skin, the wider treatment plan and how outcomes are measured by the responsible practitioner.
Is ASCE+ SRLV-E an injectable exosome treatment?
The cited DailyMed route is topical. This guide does not support injection or another route that conflicts with the exact label and local regulation.